Hi S***l,
Thanks for your quick response! Let’s plan to chat this Thursday at 3:00 PM PST,does that work for you? I’ll send a calendar invite with a video link once I hear back.
In the meantime, here’s a brief overview of the VP of Corporate Development & Strategic Partnerships role at I***r T***s and why your background is such a strong fit:
1. Company & Culture
- I***r T***s is a fast-growing biotech (200,500 employees) focused on breakthrough oncology and precision medicines.
- We pride ourselves on a collaborative, mission-driven environment that values scientific rigor and strategic growth.
2. Role & Responsibilities
- Lead and execute M&A, licensing agreements, and equity investments across pre-clinical and clinical platforms,exactly the arena where you’ve excelled at G***d S***s.
- Drive end-to-end diligence, deal structuring, and negotiations in partnership with R&D, legal, and finance teams.
- Source and cultivate high-value partnerships with startups, academic institutions, and VCs to accelerate next-gen drug discovery.
- Advise the executive team on portfolio strategy, market insights, and growth opportunities to maximize long-term value.
- Build and mentor a high-performing corporate development team, shaping a culture of excellence.
3. Career Growth & Impact
- This is a true leadership role with direct visibility to the C-suite and Board,your input will shape I***r T***s’s strategic trajectory.
- You’ll have the opportunity to scale the function, grow your team, and deepen your influence across the company.
4. Resources & Support
- I***r T***s offers a competitive salary, annual bonus, and meaningful equity.
- You’ll partner with world-class scientists and seasoned execs, with full access to in-house legal, finance, and operational support.
Does this sound in line with what you’re looking for? Let me know if Thursday at 3:00 PM PST works, or if you’d prefer Friday morning,and if you have any questions about the role or the company before we chat.
Looking forward to our conversation!
Best,
J***e
HR Recruiter, StrategyBrain